Literature DB >> 12868373

Feasibility study of Flextube reflectometry for localisation of upper airway obstruction in obstructive sleep apnea.

Natascha S Hessel1, Martin Laman, Vincent C P J van Ammers, Hans van Duijn, Nico de Vries.   

Abstract

One hundred and twenty-three patients with snoring problems and/or obstructive Sleep Apnea Syndrome (OSAS) were offered Rhinosleep Flextube-reflectometry during sleep registration to assess the upper airway. The main point of interest was patient acceptance of the procedure. 36 patients with OSAS received Rhino Flextube reflectometry. Of these, 19 (53%) completed a whole night registration with the Rhinosleep tube and 17 (47%) did not. This low success rate is multifactorial and will be discussed in detail in the text. The development of Rhinosleep is a challenge, as it improves the topical diagnostic work-up of OSAS patients. At present however various practical problems have to be solved to make it a viable alternative to sleep endoscopy.

Entities:  

Mesh:

Year:  2003        PMID: 12868373

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

1.  Current diagnostic trends in sleep disordered breathing.

Authors:  Joachim T Maurer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05

2.  Pharyngeal Swallowing During Wake and Sleep.

Authors:  Esther Guiu Hernandez; Kristin Gozdzikowska; Richard D Jones; Maggie-Lee Huckabee
Journal:  Dysphagia       Date:  2019-02-26       Impact factor: 3.438

3.  Patient discomfort in polysomnography with esophageal pressure measurements.

Authors:  Britt Oeverland; Harriet Akre; Kari J Kvaerner; Olav Skatvedt
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-30       Impact factor: 2.503

4.  The influence of pharyngeal and esophageal pressure measurements on the parameters of polysomnography.

Authors:  Johanna K Stuckenbrock; A Freuschle; I Nakajima; B A Stuck
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-19       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.